logo-loader
viewIXICO PLC

IXICO PLC secures largest ever contract win as it updates on outlook and 'strong pipeline'

IXICO PLC's (LON:IXI) Giulio Cerroni and Lammert Albers speak to Proactive London's Andrew Scott following the release of its first half trading update and news it's secured a “substantial new contract” for a late-phase open label study into Huntington’s disease.

They add they're expecting to report revenue growth of “at least 25%” year-on-year for the six months ended 31 March.

Quick facts: IXICO PLC

Price: 70 GBX

AIM:IXI
Market: AIM
Market Cap: £32.96 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

IXICO sees strong topline growth in interim results

IXICO Plc's (LON:IXI) Giulio Cerroni tells Proactive that the company is seeing topline growth of 30% in a strong set of interim results. Cerroni says the company is also seeing improvements in its gross margins and cash position. He adds that the company recently raised £5.5mln...

on 23/5/18

2 min read